Skip to main content

Header Menu

Politics
Economy
Covid-19
Science
Culture
India
International
Sports
Articles
Videos
हिन्दी

All Articles
Newsclick Articles
All Videos
Newsclick Videos

Politics
Economy
Science
Culture
India
Sports

International
Africa
Latin America
Nepal
Pakistan
Sri Lanka
US
West Asia

About Us
Grievance Redressal Mechanism

Newsletter

Search

Search

COVAXIN

WHO Decision on Emergency Use Listing of Covaxin Likely in 4-6 Weeks: Sowmya Swaminathan

BSNL

Protests & Movements

BSNL: Salary Delays Continue, Employees to Stage Hunger Strike in Protest

ADR Says 42% Cabinet Ministers Declared Criminal Cases Against Them

ADR Says 42% Cabinet Ministers Declared Criminal Cases Against Them

PTI/NewsClick Report

AIKS Says Maharashtra Govt's Farm Bills Similar to Central Laws with 'Minor Changes'

AIKS Says Maharashtra Govt's Farm Bills Similar to Central Laws with 'Minor Changes'

Cuba’s anti-COVID-19 vaccine candidate, Soberana 02 of the Finlay Vaccine Institute (IFV), showed 91.2% efficacy with a third booster shot of Soberana Plus during the third phase of clinical trials. Photo: Endrys Correa Vaillant

Cuba’s Soberana 02 Vaccine Shows 91.2% Efficacy Against COVID-19

Peoples Dispatch

Loading more...

Newsletter

Grievance Reddressal Mechanism
About Us